Best Practices for Biomarker Testing in Metastatic Melanoma

Source: OncLive, November 2023

When a patient with metastatic melanoma patient tests negative for the BRAF V600E mutation, doctors recommend sending the sample for next-generation sequencing testing which can take 2-3 weeks, during which time they may start immunotherapy if the patient has aggressive disease, but ideally should wait for results to guide treatment.
READ THE ORIGINAL FULL ARTICLE